Paul Chu Sin Chung

Dr. Paul Chu Sin Chung

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PCPaul Chu Sin Chung
Paul Chu Sin Chung
BKBrigitte L. Kieffer
Brigitte L. Kieffer

1 September 2014 in Neuroscience
Verified
Journal Article
Closed access
OGO. Gardon
O. Gardon
LFL. Faget
L. Faget
PCPaul Chu Sin Chung
Paul Chu Sin Chung
AMA. Matifas
A. Matifas
dominique massottedominique massotte
dominique massotte
BKB.L. Kieffer
B.L. Kieffer

30 May 2014 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PLPierre Eric Lutz
Pierre Eric Lutz
GAGulebru Ayranci
Gulebru Ayranci
PCPaul Chu Sin Chung
Paul Chu Sin Chung
AMAudrey Matifas
Audrey Matifas
PKPascale Koebel
Pascale Koebel
BKBrigitte L Kieffer
Brigitte L Kieffer

1 February 2015 in Behavioural Brain Research
Verified
Journal Article
Closed access
PCPaul Chu Sin Chung
Paul Chu Sin Chung
ABAnnie Boehrer
Annie Boehrer
ASAline Stephan
Aline Stephan
AMAudrey Matifas
Audrey Matifas
GSGrégory Scherrer
Grégory Scherrer
BKBrigitte L. Kieffer
Brigitte L. Kieffer

Verified
Journal Article
Open access
PDF file
EKElena A. Konnova
Elena A. Konnova
ADAlexandru-Florian Deftu
Alexandru-Florian Deftu
PCPaul Chu Sin Chung
Paul Chu Sin Chung
MPMarie Pertin
Marie Pertin
GKguylene kirschmann
guylene kirschmann
MSMarc Suter
Marc Suter
Satellite glial cells (SGCs), enveloping primary sensory neurons’ somas in the dorsal root ganglion (DRG), contribute to neuropathic pain upon nerve injury. Glial fibrillary acidic protein (GFAP) serves as an SGC activation marker, though its DRG satellite cell specificity is debated. We employed the hGFAP-CFP transgenic mouse line, designed for astrocyte studies, to explore its expression within the peripheral nervous system (PNS) after spared nerve injury (SNI). We used diverse immunostaining techniques, Western blot analysis, and electrophysiology to evaluate GFAP+ cell changes. Post-SNI, GFAP+ cell numbers increased without proliferation, and were found near injured ATF3+ neurons. GFAP+ FABP7+ SGCs increased, yet 75.5% of DRG GFAP+ cells lacked FABP7 expression. This suggests a significant subset of GFAP+ cells are non-myelinating Schwann cells (nmSC), indicated by their presence in the dorsal root but not in the ventral root which lacks unmyelinated fibres. Additionally, patch clamp recordings from GFAP+ FABP7−cells lacked SGC-specific Kir4.1 currents, instead displaying outward Kv currents expressing Kv1.1 and Kv1.6 channels specific to nmSCs. In conclusion, this study demonstrates increased GFAP expression in two DRG glial cell subpopulations post-SNI: GFAP+ FABP7+ SGCs and GFAP+ FABP7− nmSCs, shedding light on GFAP’s specificity as an SGC marker after SNI.

1 February 2015 in Biological Psychiatry
Verified
Journal Article
Closed access
PCPaul Chu Sin Chung
Paul Chu Sin Chung
HKHelen L. Keyworth
Helen L. Keyworth
EGElena Martín García
Elena Martín García
PCPauline Charbogne
Pauline Charbogne
EDEmmanuel Darcq
Emmanuel Darcq
BKBrigitte L. Kieffer
Brigitte L. Kieffer